Langtry A, Rabadan R, Alonso L, Filip I, Sabroso-Lasa S, Moreno-Oya A, Lawlor R, Carrato A, Alvarez-Gallego R, Iglesias M, Molero X, Löhr MJ, Michalski CW, Perea J, O'Rorke M, Barberà VM, Tardón A, Farré A, Muñoz-Bellvís L, Crnogorac-Jurcevic T, Domínguez-Muñoz E, Gress TM, Greenhalf W, Sharp L, Balsells J et al. (2025)
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis
Nat Commun, 16 (1), 10769
DOI 10.1038/s41467-025-65811-y, PubMed 41315260

Alves N, Schuurmans M, Rutkowski D, Saha A, Vendittelli P, Obuchowski N, Liedenbaum MH, Haldorsen IS, Molven A, Yakar D, Geerdink J, van Koeverden S, Riviere DM, Venderink W, de Haas R, Kim N, Löhr JM, Suman G, Maier-Hein KH, Hahn HK, Wang W, Yuille AL, Kambadakone A, Fishman EK, Verbeke C et al. (2025)
Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study
Lancet Oncol (in press)
DOI 10.1016/S1470-2045(25)00567-4, PubMed 41275871

Amrutkar M, Li Y, Finstadsveen AV, Verbeke CS, Gladhaug IP (2025)
Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine
Proteomes, 13 (4)
DOI 10.3390/proteomes13040048, PubMed 41133621